Published in Acta Virol on July 01, 1983
Interactions of human cytomegalovirus with human fibroblasts. J Bacteriol (1966) 2.00
Thymidine-kinase in cytomegalovirus infected cells. Arch Virol (1976) 1.96
Temperature-sensitive mutants of herpes simplex virus. Virology (1970) 1.83
Correlation between infectivity and physical virus particles in human cytomegalovirus. J Bacteriol (1966) 1.71
Thermoinactivation of human cytomegalovirus. J Bacteriol (1966) 1.56
Human cytomegalovirus: properties of the complement-fixing antigen. J Immunol (1966) 1.44
Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines. J Natl Cancer Inst (1970) 1.43
WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland. Bull World Health Organ (1972) 1.42
Ribonucleotides linked to DNA of herpes simplex virus type 1. J Virol (1974) 1.28
Papovaviridae. Intervirology (1974) 1.26
Early DNA-binding polypeptides of Epstein-Barr virus. Virology (1981) 1.15
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer (1984) 1.14
Association of some supraglottic laryngeal carcinomas with EB virus. Int J Cancer (1983) 1.07
Studies on the growth of herpes simplex virus in lymphoblastoid cells. Acta Virol (1971) 1.06
Increased oncogenicity and synthesis of herpesvirus antigens in hamster cells exposed to herpes simplex type-2 virus. J Natl Cancer Inst (1973) 1.05
Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review. IARC Sci Publ (1975) 1.03
Replicating DNA of herpes simplex virus type 1. Intervirology (1976) 1.03
Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil. J Natl Cancer Inst (1984) 1.00
Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells. Intervirology (1981) 0.99
Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells. Virology (2001) 0.98
Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence. J Natl Cancer Inst (1974) 0.97
Absence of cytomegalovirus DNA from adenocarcinoma of the colon. Intervirology (1980) 0.92
Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma. Int J Cancer (2000) 0.91
The use of an in vitro test of delayed type hypersensitivity for the detection of specific tumor antigen of transplantation type induced by SV 40 virus. Z Immunitatsforsch Allerg Klin Immunol (1968) 0.91
Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides. J Gen Virol (1991) 0.90
Replication of cytomegalovirus in human epitheloid diploid cell line. Arch Virol (1976) 0.90
Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol (1999) 0.89
Phosphonylmethyl ethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase. Antiviral Res (1990) 0.89
Comparison of genetic properties of influenza viruses before and after repeated passages in monkey kidney cell culture. Acta Virol (1968) 0.88
Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from adenoma and adenocarcinoma of the colon. Acta Virol (1988) 0.88
Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination. J Gen Virol (1991) 0.87
Preparation of antisera against the S antigen of influenza A virus by immunization of guinea pigs with internal S antigen. Arch Gesamte Virusforsch (1967) 0.87
Determination of herpes simplex virus type-specific antibodies by solid-phase RIA on Helix pomatia lectin-purified antigens. J Infect Dis (1984) 0.87
Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation. Arch Virol (1984) 0.87
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int J Cancer (1984) 0.86
Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus. Arch Gesamte Virusforsch (1967) 0.86
Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. J Gen Virol (1990) 0.86
Variation in neurovirulence of NWS influenza virus after repeated passages in different tissue culture systems. I. Derivation and neurotropic activity of NWS virus lines. Arch Gesamte Virusforsch (1968) 0.86
A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine. Prog Med Virol (1967) 0.85
Multiplicity reactivation in UV-irradiated herpes simplex type 1 virus. Intervirology (1973) 0.85
Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia. Int J Cancer (1996) 0.85
Human papillomavirus infection and cervical carcinoma. Clin Obstet Gynecol (2000) 0.85
Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. J Clin Oncol (1997) 0.84
Linkage between reproductive capacity at increased temperature and neurotropic activity in A-NWS HONi (HON1) influenza virus. Infect Immun (1974) 0.84
Herpes simplex type 2 virus and cervical neoplasia. Adv Cancer Res (1987) 0.83
Plaque formation by NWS influenza virus in a human diploid cell strain. Acta Virol (1967) 0.83
Effect of 3-beta-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants. Arch Virol (1998) 0.83
Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine (1995) 0.83
Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract. Arch Gesamte Virusforsch (1965) 0.83
Antibodies to EB virus capsid antigen and to soluble antigen of lymphoblastoid cells in infectious mononucleosis patients. Int J Cancer (1972) 0.83
Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer (1998) 0.83
Presence of Epstein-Barr virus DNA in tonsillar tissues. Acta Virol (1981) 0.83
Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16. Br J Cancer (2001) 0.82
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16. Int J Oncol (1999) 0.82
Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines. Arch Gesamte Virusforsch (1970) 0.82
Structure of herpes simplex virus DNA: topography of the molecule. I. Absence of circularly permuted sequences. Virology (1975) 0.82
Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years. Arch Gesamte Virusforsch (1972) 0.82
Comparative detection of herpesviruses in tissue specimens by in situ hybridization and immunofluorescence. Acta Virol (1986) 0.82
Genetic interaction between two influenza A-WS virus mutants. I. Characterization of the mutants. Acta Virol (1971) 0.81
Electron microscopy of binding of Epstein-Barr virus (EBV) nuclear antigen (EBNA-1) to EBV DNA. Virology (1987) 0.81
Production and some properties of neutralizing antigens of herpes simplex virus. Acta Virol (1977) 0.81
Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. J Infect Dis (1994) 0.81
Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions. Sex Transm Infect (2003) 0.81
Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. J Gen Virol (1982) 0.81
Genetic interaction between two influenza A-WS virus mutants. II. Genetic interaction between NWS-D and WS-MK viruses in human diploid cells and hamster embryo fibroblasts. Acta Virol (1971) 0.81
Ultrastructural changes induced by influenza viruses in permissive and nonpermissive cells. Virology (1977) 0.81
Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours. Int J Oncol (2003) 0.80
Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants. Arch Gesamte Virusforsch (1972) 0.80
Variation in neurovirulence of NWS influenza virus after repeated passages in different tissue culture systems. II. Correlation between neurovirulence and some other genetic markers. Arch Gesamte Virusforsch (1968) 0.80
The nature of adenovirus persistence in human adenoid vegetations. Arch Virol (1975) 0.80
Genetic recombination between plaque-purified mutants of influenza A-NWS and A-2-Singapore viruses. Arch Gesamte Virusforsch (1970) 0.80
Characteristics of lipid A-protein complex from endotoxin of Shigella dysenteriae type 1 (S and R strains). Infect Immun (1979) 0.80
Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines. J Gen Virol (1983) 0.80
Demonstration of Epstein-Barr virus in malignant non-Hodgkin's lymphomas. Oncology (1986) 0.80
Immunogenicity of subviral herpes simplex virus preparations. I. Formation of neutralizing antibodies in different animal species after administration of herpes simplex virus solubilized antigens. Arch Virol (1979) 0.79
Presence of antibody reactive with synthetic peptide derived from L2 open reading frame of human papillomavirus types 6b and 11 in human sera. Acta Virol (1990) 0.79
Immunological profiles of patients with chronic myeloid leukaemia. I. State before the start of treatment. Folia Biol (Praha) (2006) 0.79
Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species. J Gen Virol (1979) 0.79
Development of antibodies against viral and tumor antigens of papovavirus SV40 in monkeys. Proc Soc Exp Biol Med (1967) 0.79
Inhibitory effect of herpes simplex virus type 1 on type 2 virus replication. J Gen Virol (1976) 0.79
Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects. Folia Biol (Praha) (2004) 0.79
Cytosine-arabinoside does not inhibit incorporation of 3H-thymidine in herpes simplex virus transformed cells. Arch Virol (1977) 0.78
Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant. J Gen Virol (1991) 0.78